SOLICITATION NOTICE
66 -- BD FACSAria System Upgrade
- Notice Date
- 8/9/2016
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, Maryland, 20892-7902
- ZIP Code
- 20892-7902
- Solicitation Number
- HHS-NIH-NHLBI-CSB-(HG)-2016-248-DM
- Archive Date
- 8/30/2016
- Point of Contact
- Dorothy Maxwell, Phone: 301-435-0352
- E-Mail Address
-
maxwelld@mail.nih.gov
(maxwelld@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- INTRODUCTION: THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). (Specified Brand Name: BD Biosciences) NO REFURBISHED OR USED SYSTEMS UPGRADE ARE ACCEPTABLE. THIS IS A NOTICE OF INTENT, NOT A REQUEST FOR A PROPOSAL. A SOLICITATION DOCUMENT WILL NOT BE ISSUED AND PROPOSALS WILL NOT BE REQUESTED. The National Heart, Lung, and Blood Institute (NHLBI) Office of Acquisition (OA) on behalf of the National Human Genome Research Institute, (NHGRI), intends to negotiate and award a purchase order on a non-competitive sole source basis to BD Biosciences, 1 Becton Drive, Franklin Lakes, NJ 07417, to procure the following: Procurement: • Product Number: 649602 00382906496027; Product Description: Kit 3 And 4 Laser 561nm FC Upgrade Aria IIU; Unit of Measure: Each; Quantity: One. Background: The National Institute of Health (NIH) is the nation's leading medical research agency and the primary Federal agency seeking fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. The National Human Genome Research Institute (NHGRI), mission has expanded to encompass a broad range of studies aimed at understanding the structure and function of the human genome and its role in health and disease. A critical part of the NHGRI mission continues to be the study of the ethical, legal and social implications (ELSI) of genome research. Genetics and Molecular Biology Branch (GMBB) investigators use state-of-the-art genetic and genomic technologies to study the genomes of humans and other organisms and disease mechanisms. Their goal is to demonstrate that research findings and opportunities derived from genetic and genomic technologies may be translated into improved diagnosis, treatments and prevention of human diseases. Using the excellent resources of NHGRI intramural laboratories, the NIH Clinical Center and intramural collaborations across NIH, the branch is engaged in basic, translational and clinical research, bringing the latest genomic and genetic technologies to the study of human disease. GMBB investigators develop and quickly evaluate novel translational approaches and advanced technologies. In addition, collaborations with the NIH Clinical Center, the NIH Intramural Sequencing Center and the NIH Chemical Genomics Center support projects that expand the breadth of single-investigator laboratories. The NHGRI core facilities are equally important components of all GMBB research efforts, giving GMBB investigators access to state-of-the-art bioinformatic, transgenic-animal, flow-cytometry, genomic and cytogenetic technologies. These resources have allowed GMBB investigators to develop clinical trials for gene therapy of immune deficiency and preclinical development of gene therapy for metabolic disorders. In addition, GMBB investigators have discovered disease genes and identified small molecules to treat inherited diseases and malignancies. Purpose and Objectives : The NHGRI Flow Cytometry Core, is actively involved in a variety of applications including; the isolation of tissue and blood cell populations for animal transplantation experiments; isolation of cell sub-populations and single cells from defined populations for analyses of functional cellular properties; gene transcription profiles; chromatin modifications and transcription factor binding; as well as high throughput functional screening of enhancer regions. The upgrade of this instrument will allow us to increase our productivity and provide current state of the art technology to investigators NHGRI Flow Cytometry Core would like to add a 561nm laser to the existing the BD Biosciences FACSAria, thus increasing the systems utility and bringing the system to current levels of technology. The incorporation of the 561-nm laser into the BD FACSAria will provide the capability to better separate the excitation and emission of FITC and PE and can be used for fluorescent proteins such as mCherry and dsRed, allowing the Core to provide appropriate current technology. This would allow both sorters to be used interchangeably and allow both machines to be used simultaneously, so that more sorts can be done in a day thereby increasing output. Moreover, this would not restrict the most complicated sorts to a specific instrument. Other Considerations: The proposed upgrades will add enhanced cell feature detection capability to the existing flow cytometer providing a 561nm laser for additional fluorochrome excitation and photomultiplier detectors to quantitate these additional signals generated during flow cytometry cell sorting. Installation by factory trained BD FACSAria hardware field engineer and one year warranty will also be included. The system upgrade will be procured directly from BD Biosciences, which is the FACSAria flow cytometer manufacturer. This upgrade contains proprietary items and is integrated into nearly every system of the cytometer. Anticipated Period of Performance: Delivery Upon Award Deliverables: The Contractor shall deliver equipment upgrade to NIH, 49 Convent Drive, Bethesda, Maryland. Inspection and Acceptance : Upon delivery, investigators at the National Heart, Lung and Blood (NHLBI), National Institute of Human Genome Research Institute (NHGRI) will inspect the equipment before acceptance. Regulatory Authority : This acquisition is conducted under the authority of the Federal Acquisition Regulations (FAR) Subpart 13.106-1(b) Soliciting from a single source and is not expected to exceed the simplified acquisition threshold, only one responsible source and no other supplies or services will satisfy agency requirements. This requirement is under the Simplified Acquisition Threshold of $150,000.00. Statutory Authority: This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Closing Statement : Industry Classification (NAICS) Code is 334516, Analytical Laboratory Instrument Manufacturing and small business size standard is 1000. The acquisition is being conducted under FAR Part 13, simplified acquisition procedures, therefore the requirements of FAR Part 6 B Competitive Requirements are not applicable (FAR Part 6.001). The resultant Contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 05-89 (July 14, 2016). This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by August 15, 2016 and must reference synopsis number HHS-NIH-NHLBI-CSB-(HG)-2016-248-DM by 7:30 a.m. Eastern Time, may be submitted to the National, Heart, Lung and Blood Institute, Office of Acquisition, COAC Services Branch, 6701 Rockledge Drive, Suite 6149, Bethesda, Maryland 20892-7902, Attention: Dorothy Maxwell,Contracting Officer. Response may be submitted electronically to maxwelld@mail.nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NHLBI/HHS-NIH-NHLBI-CSB-(HG)-2016-248-DM/listing.html)
- Place of Performance
- Address: NIH 49 Convent Drive, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN04215991-W 20160811/160809235730-a4c8e21edac1034e6c96a021ef96e5d5 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |